Image Analysis
Image Analysis is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy
Sponsor Cns Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available1 trial-level finding · Read insights
- The study operated at 47 centers in the United States, France, Italy, Spain, and Switzerland, with 58 investigators due to principal-investigator changes during the study.
These findings describe the trial, not the service provider’s performance or responsibility.
A randomized double-blind placebo-controlled multicentre study to assess safety, tolerability, pharmacokinetics and efficacy of Radotinib in Parkinson’s disease.
Sponsor Il-Yang Pharm Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Safety, Tolerability and Efficacy of AGA2118 in Postmenopausal Women with Low Bone Mineral Density
Sponsor Angitia Inc. Ltd.
- Start (EU)
- Latest update
- Estimated end
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intra-Articular Allocetra in Patients with Primary Knee Osteoarthritis
Sponsor Enlivex Therapeutics Ltd.
- Start (EU)
- Latest update
- Estimated end
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults with Type I, III, or IV Osteogenesis Imperfecta (OI)
Sponsor Angitia Inc. Ltd.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Ficlatuzumab in Combination with Cetuximab in Participants with Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (FIERCE-HN)
Sponsor Aveo Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2, open-label, imaging study to explore the effects of sonelokimab in patients with active psoriatic arthritis or axial spondyloarthritis
Sponsor MoonLake Immunotherapeutics AG
- Start (EU)
- Latest update
- Estimated end
- Not reported
An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients with Waldenstrom Macroglobulinemia (CLOVER-WaM)
Sponsor Cellectar Biosciences Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2 open-label imaging study to explore the effects of sonelokimab in patients with active axial spondyloarthritis
Sponsor MoonLake Immunotherapeutics AG
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Image Analysis?
The 2026-10-09 snapshot links Image Analysis to 9 distinct CTIS trials. Recorded services include Data management, DEXA and X-rays, Image Analysis, Imaging, among 10 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Image Analysis?
The most frequently recorded therapeutic areas are Neurology, Metabolic Disorders, Musculoskeletal, Solid Tumor Oncology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Image Analysis conducted?
The linked trials record locations in 14 countries, including France, Germany, Denmark, Spain, Poland. These are trial locations, not confirmed office locations or countries where Image Analysis delivered services.
What can this page tell me about Image Analysis's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Image Analysis. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Image Analysis Limited